American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer (Q33674179)

28 July 2017

1 reference

title

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer (English)

1 reference

28 July 2017

1 reference

1 reference

Nag S

1

1 reference

28 July 2017

Beyer D

2

1 reference

28 July 2017

Friedland J

3

1 reference

28 July 2017

Grimm P

4

1 reference

28 July 2017

Nath R

5

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

International Journal of Radiation Oncology Biology Physics

28 July 2017

1 reference

28 July 2017

44

1 reference

28 July 2017

789-799

1 reference

28 July 2017

4

1 reference

Prostate specific antigen based disease control following ultrasound guided 125iodine implantation for stage T1/T2 prostatic carcinoma

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Brachytherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Radioisotopic implantation for carcinoma of the prostate: does it work better than it used to?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Transperineal ultrasound-guided radioactive seed implantation for organ-confined carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

A dose-response study for I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Short-term freedom from disease progression after I-125 prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

A survey of current clinical practice of permanent prostate brachytherapy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Complication of 125 iodine implantation and pelvic lymphadenectomy for prostatic cancer with special reference to patients who had failed external beam therapy as their initial mode of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Complications of 125 Iodine Implantation and Pelvic Lymphadenectomy in the Treatment of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

125iodine reimplantation for locally progressive prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Short-term morbidity from CT-planned transperineal I-125 prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Relationship between perineural tumor invasion on needle biopsy and radical prostatectomy capsular penetration in clinical stage B adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Nerve-sparing radical prostatectomy: evaluation of results after 250 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Does microinvasion of the capsule and/or micrometastases in regional lymph nodes influence disease-free survival after radical prostatectomy?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Morphometric and Clinical Studies on 68 Consecutive Radical Prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Positive surgical margins at radical prostatectomy: importance of the apical dissection.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Development of Prostatic Carcinoma: Morphometric and pathologic features of early stages

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Invasion of Denonvilliers' fascia in radical prostatectomy specimens.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

The role of perineural space invasion in the local spread of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Pathologic parameters and flow cytometric ploidy analysis in predicting recurrence in carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Incidence of surgical margin involvement in various forms of radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathologic findings on biochemical disease-free outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Predictive value of contralateral biopsies in unilaterally palpable prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Use of endorectal surface coil magnetic resonance imaging for local staging of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

An improved method for computerized tomography-planned transperineal 125iodine prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Retropubic Implantation of Iodine 125 in the Treatment of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Spacing nomograph for interstitial implants of 125 I seeds

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Quantifying the effect of dose inhomogeneity in brachytherapy: application to permanent prostatic implant with 125I seeds

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

CT-based optimized planning for transperineal prostate implant with customized template

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

A simple method to stabilize the prostate during transperineal prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Improvement in dosimetry of ultrasound-guided prostate implants with the use of multiple stabilization needles

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Clinical impact of implementing the recommendations of AAPM Task Group 43 on permanent prostate brachytherapy using 125I. American Association of Physicists in Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

A method for implementing the American Association of Physicists in Medicine Task Group-43 dosimetry recommendations for 125I transperineal prostate seed implants on commercial treatment planning systems

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

The coupling of anisotropy and radial dose functions for 103Pd and 125I for use with a commercial treatment planning system.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Transrectal ultrasound-guidedinterstitial radiation therapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Guided brachytherapy for treatment of confined prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

A comparison of radial dose functions for 103Pd, 125I, 145Sm, 241Am, 169Yb, 192Ir, and 137Cs brachytherapy sources

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Permanent implants using Au-198, Pd-103 and I-125: radiobiological considerations based on the linear quadratic model

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Cell kinetic measurements in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

The relative biological effectiveness of I-125 and Pd-103.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Pulmonary embolization of iodine-125 seeds following prostate implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Low risk of perioperative infection without prophylactic antibiotics for transperineal prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

A CT-based evaluation method for permanent implants: application to prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Comparison of MRI- and CT-based post-implant dosimetric analysis of transperineal interstitial permanent prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

CT-based dosimetry for transperineal I-125 prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Analysis of biopsy findings and implant quality following ultrasonically-guided 125I implantation for localised prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Treatment of carcinoma of the prostate by interstitial radiation with radio-active gold (Au 198): a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Failure of open radioactive 125iodine implantation to control localized prostate cancer: a study of 41 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Clinical results of early stage prostatic cancer treated by pelvic lymphadenectomy and 125iodine implants

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

External beam irradiation versus 125 iodine implant in the definitive treatment of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Transperineal interstitial implantation of prostate cancer: a new method

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Transperineal percutaneous I-125 implant of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Radioactive iodine-125 implantation for cancer of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900069-3

7 January 2021

10.1016/S0360-3016(99)00069-3

Identifiers

DOI

1 reference

release_qbekzgbnevh73b6wsqd2kxf454

28 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qbekzgbnevh73b6wsqd2kxf454

24 November 2022

mapped directly with Wikidata item

1 reference